Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often ...

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

Research indicates that mental health conditions such as depression, schizophrenia, and bipolar disorder may be linked to ...

MONTREAL (AP) — MONTREAL (AP) — Theratechnologies Inc. (THTX) on Thursday reported earnings of $3.1 million in its fiscal third quarter. The Montreal-based company said it had profit of 6 cents per ...

Viking Therapeutics (VKTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

While PCOS cannot be reversed, balancing the hormonal level can help reduce the symptoms significantly. Following a healthy ...

The results of a new study published in The Lancet Psychiatry journal highlighted the need for routinely checking electrolyte ...

AstraZeneca boosts cardiovascular pipeline with exclusive license agreement for YS2302018, a potential treatment for ...

AstraZeneca teams up with CSPC in a $1.92 billion deal to develop YS2302018, a novel Lp(a) disruptor aimed at treating ...

(RTTNews) - Viking Therapeutics, Inc. (VKTX), Wednesday announced positive data from Phase 1b study of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare and often fatal ...